BERINERT®

Berinert®

FDA INDICATION: Berinert is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. Package Insert

FORM: Lyophilized

DISTRIBUTOR: CSL Behring

ROUTE OF ADMINISTRATION: Intravenous

DOSAGE STRENGTH500 IU

DILUENT SIZE: 10 mL

DOSE: Administer 20 units per kg body weight

MIXING DEVICE: Mix2Vial®

SELF-ADMINISTRATION: Yes, after teaching

STORAGE: Store at 2–25°C (36–77°F). Do not freeze.

HALF-LIFE: 16.7 ± 5.8 hours (pediatric), 18.4 ± 3.5 hours (adults)

OTHER WEBSITES: allabouthae.comberinert.com